Reset filter
Keywords
Urology ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
    1. 7.1. Anesthesiology
    1. 7.2. Dermatology
    1. 7.3. ENT
    1. 7.4. Geriatrics
    1. 7.5. Gynecology/Obstetrics
    1. 7.6. Internal Medicine
      1. Hematology
      1. Infectious Diseases
      1. Cardiology/Angiology
      1. Pneumology
      1. Gastroenterology
      1. Nephrology
      1. Endocrinology/Metabolic Diseases
      1. Rheumatology
    1. 7.7. Neurology
    1. 7.8. Ophthalmology
    1. 7.9. Palliative Care
    1. 7.10. Pathology/Forensics
    1. 7.11. Pediatrics
    1. 7.12. Psychiatry/Psychosomatics
    1. 7.13. Radiology
    1. 7.14. Surgery
      1. General/Visceral Surgery
      1. Neurosurgery
      1. Plastic Surgery
      1. Thoracic Surgery
      1. Trauma/Orthopedics
      1. Vascular Surgery
    1. 7.15. Urology
    1. 7.16. Dental Medicine/OMS
Selected data models

You must log in to select data models for download or further analysis.

392 Search results.
Relevance Rating New first Old first

Swedish Bladder Cancer Registry - Cystectomy - Follow-Up

- 9/27/21 - 1 form, 5 itemgroups, 106 items, 2 languages
Itemgroups: General Information, Preoperative Data, Perioperative Data, Postoperative Data, Complications and Reoperations
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Cystectomy - Follow-Up

Preoperative MRI of Prostate Cancer NCT01347320 - Eligibility

- 5/29/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01347320

Eligibility Bladder Cancer NCT01954173

- 8/18/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Adjuvant Radiation for High Risk Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01954173

Swedish Bladder Cancer Registry - 5-Year Follow-Up

- 11/19/17 - 1 form, 2 itemgroups, 15 items, 2 languages
Itemgroups: General Information, Follow-Up
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ 5-year Follow-Up

Swedish Bladder Cancer Registry - Treatment of Primary Tumor

- 11/15/17 - 1 form, 2 itemgroups, 30 items, 2 languages
Itemgroups: General Information, Treatment of Primary Tumor
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Treatment of Primary Tumor

Swedish Bladder Cancer Registry - Registry

- 11/15/17 - 1 form, 2 itemgroups, 27 items, 2 languages
Itemgroups: Registry, Tasks for Primary Diagnosis
Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Registry

Eligibility Bladder Cancer NCT00389155

- 10/4/17 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00389155

Eligibility Prostate Cancer NCT02326246

- 1/16/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
MRI in Active Surveillance of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02326246

Eligibility Prostate Cancer NCT02485379

- 6/22/19 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Assessment of Prostate MRI Before Prostate Biopsies; ODM derived from: https://clinicaltrials.gov/show/NCT02485379

Eligibility Prostate Cancer NCT02404428

- 6/18/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Utilizing MRI to Study the Effect of Sulforaphane on Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02404428

Eligibility Prostate Cancer NCT01705028

- 9/18/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Assessment of Amide-Proton-Transfer MRI in Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01705028

Eligibility Prostate Cancer NCT02303054

- 6/17/19 - 1 form, 2 itemgroups, 20 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
MRI-Targed Focal Ablation of the Prostate in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02303054

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial